David Calkins

Team tracking new options to treat glaucoma

Three years ago, a team of researchers led by David Calkins, Ph.D., vice chair and director of Research at the Vanderbilt Eye Institute, showed that the first sign of injury in glaucoma, the leading cause of blindness in the United States, occurs in the brain.

Calkins lands award from Research to Prevent Blindness

David Calkins, Ph.D., vice chair and director of Research for the Vanderbilt Eye Institute, was recently awarded a Research to Prevent Blindness (RPB) Senior Scientific Investigator Award.

Glaucoma research highlighted at VEI symposium

Vision experts from around the country recently gathered at the 2012 Vanderbilt Eye Institute symposium “Regenerative Medicine in Glaucoma” to discuss the impact that regenerative medicine has on neurobiological diseases.

Event celebrates Vanderbilt endowed chair holders

Twelve Vanderbilt University faculty members were honored for extraordinary contributions to their respective fields during an Aug. 28 celebration of endowed chair holders at the Student Life Center.

Grants bolster eye research at Vanderbilt

Research to Prevent Blindness has awarded a grant of $100,000 to Vanderbilt’s Department of Ophthalmology and Visual Sciences to support research into the causes, treatment and prevention of blinding diseases.

1 2